Literature DB >> 20972647

Intensive versus conventional insulin therapy in critically ill neurologic patients: still searching for the sweet spot.

Jennifer A Frontera.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20972647     DOI： 10.1007/s12028-010-9458-7

Source DB:  PubMed          Journal:  Neurocrit Care        ISSN： 1541-6933            Impact factor:   3.210


× No keyword cloud information.
  29 in total

1.  Intensive insulin therapy in the neurocritical care setting is associated with poor clinical outcomes.

Authors:  Carmelo Graffagnino; Ananda R Gurram; Bradley Kolls; DaiWai M Olson
Journal:  Neurocrit Care       Date:  2010-12       Impact factor: 3.210

2.  Intensive insulin therapy reduces microdialysis glucose values without altering glucose utilization or improving the lactate/pyruvate ratio after traumatic brain injury.

Authors:  Paul Vespa; Robert Boonyaputthikul; David L McArthur; Chad Miller; Maria Etchepare; Marvin Bergsneider; Thomas Glenn; Neil Martin; David Hovda
Journal:  Crit Care Med       Date:  2006-03       Impact factor: 7.598

3.  Glucose-potassium-insulin infusions in the management of post-stroke hyperglycaemia: the UK Glucose Insulin in Stroke Trial (GIST-UK).

Authors:  Christopher S Gray; Anthony J Hildreth; Peter A Sandercock; Janice E O'Connell; Donna E Johnston; Niall E F Cartlidge; John M Bamford; Oliver F James; K George M M Alberti
Journal:  Lancet Neurol       Date:  2007-05       Impact factor: 44.182

4.  The impact of hyperglycemia on patients with severe brain injury.

Authors:  Elan Jeremitsky; Laurel A Omert; C Michael Dunham; Jack Wilberger; Aurelio Rodriguez
Journal:  J Trauma       Date:  2005-01

5.  Accuracy of bedside capillary blood glucose measurements in critically ill patients.

Authors:  C Dana Critchell; Vincent Savarese; Amy Callahan; Christine Aboud; Serge Jabbour; Paul Marik
Journal:  Intensive Care Med       Date:  2007-09-01       Impact factor: 17.440

6.  Persistent poststroke hyperglycemia is independently associated with infarct expansion and worse clinical outcome.

Authors:  Tracey A Baird; Mark W Parsons; Thanh Phan; Thanh Phanh; Ken S Butcher; Patricia M Desmond; Brian M Tress; Peter G Colman; Brian R Chambers; Stephen M Davis
Journal:  Stroke       Date:  2003-07-31       Impact factor: 7.914

7.  A prospective, randomized, study comparing early percutaneous dilational tracheotomy to prolonged translaryngeal intubation (delayed tracheotomy) in critically ill medical patients.

Authors:  Mark J Rumbak; Michael Newton; Thomas Truncale; Skai W Schwartz; James W Adams; Patrick B Hazard
Journal:  Crit Care Med       Date:  2004-08       Impact factor: 7.598

8.  Guidelines for the early management of adults with ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups: The American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists.

Authors:  Harold P Adams; Gregory del Zoppo; Mark J Alberts; Deepak L Bhatt; Lawrence Brass; Anthony Furlan; Robert L Grubb; Randall T Higashida; Edward C Jauch; Chelsea Kidwell; Patrick D Lyden; Lewis B Morgenstern; Adnan I Qureshi; Robert H Rosenwasser; Phillip A Scott; Eelco F M Wijdicks
Journal:  Circulation       Date:  2007-05-22       Impact factor: 29.690

9.  Impact of medical complications on outcome after subarachnoid hemorrhage.

Authors:  Katja E Wartenberg; J Michael Schmidt; Jan Claassen; Richard E Temes; Jennifer A Frontera; Noeleen Ostapkovich; Augusto Parra; E Sander Connolly; Stephan A Mayer
Journal:  Crit Care Med       Date:  2006-03       Impact factor: 7.598

10.  Intensive insulin therapy and pentastarch resuscitation in severe sepsis.

Authors:  Frank M Brunkhorst; Christoph Engel; Frank Bloos; Andreas Meier-Hellmann; Max Ragaller; Norbert Weiler; Onnen Moerer; Matthias Gruendling; Michael Oppert; Stefan Grond; Derk Olthoff; Ulrich Jaschinski; Stefan John; Rolf Rossaint; Tobias Welte; Martin Schaefer; Peter Kern; Evelyn Kuhnt; Michael Kiehntopf; Christiane Hartog; Charles Natanson; Markus Loeffler; Konrad Reinhart
Journal:  N Engl J Med       Date:  2008-01-10       Impact factor: 91.245
View more
  1 in total

Review 1.  Stress hyperglycemia, insulin treatment, and innate immune cells.

Authors:  Fangming Xiu; Mile Stanojcic; Li Diao; Marc G Jeschke
Journal:  Int J Endocrinol       Date:  2014-05-08       Impact factor: 3.257
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.